SEC Form 3 · accession 0001746372-26-000005
LB PHARMACEUTICALS INC · LBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph M Miller
Officer — Chief Financial Officer
Period of report
Sep 2, 2026
Accepted (ET)
Sep 14, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001691082
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
No Table II lines on this filing.